149 related articles for article (PubMed ID: 12901729)
21. Human cytomegalovirus as a potential etiologic agent in recurrent aphthous ulcers and Behçet's disease.
Sun A; Chang JG; Kao CL; Liu BY; Wang JT; Chu CT; Yuan JH; Chiang CP
J Oral Pathol Med; 1996 May; 25(5):212-8. PubMed ID: 8835817
[TBL] [Abstract][Full Text] [Related]
22. HLA-A, B (Class I) and HLA-DR, DQ (Class II) antigens in Turkish patients with recurrent aphthous ulceration and Behçet's disease.
Pekiner FN; Aytugar E; Demirel GY; Borahan MO
Med Princ Pract; 2013; 22(5):464-8. PubMed ID: 23485763
[TBL] [Abstract][Full Text] [Related]
23. Immunolocalization of tumor necrosis factor-alpha expressing cells in recurrent aphthous ulcer lesions (RAU).
Natah SS; Häyrinen-Immonen R; Hietanen J; Malmström M; Konttinen YT
J Oral Pathol Med; 2000 Jan; 29(1):19-25. PubMed ID: 10678712
[TBL] [Abstract][Full Text] [Related]
24. Release of soluble tumor necrosis factor receptors from polymorphonuclear cells of breast cancer patients.
Jabłońska E; Pietruska Z
Arch Immunol Ther Exp (Warsz); 1997; 45(5-6):449-53. PubMed ID: 9437501
[TBL] [Abstract][Full Text] [Related]
25. Salivary interleukin-6 and tumor necrosis factor-alpha in patients with recurrent aphthous ulceration.
Boras VV; Lukac J; Brailo V; Picek P; Kordić D; Zilić IA
J Oral Pathol Med; 2006 Apr; 35(4):241-3. PubMed ID: 16519772
[TBL] [Abstract][Full Text] [Related]
26. The role of specific cow's milk proteins in the etiology of recurrent aphthous ulcers.
Besu I; Jankovic L; Konic-Ristic A; Raskovic S; Besu V; Djuric M; Cakic S; Magdu IU; Juranic Z
J Oral Pathol Med; 2013 Jan; 42(1):82-8. PubMed ID: 22924810
[TBL] [Abstract][Full Text] [Related]
27. Expression of Th1/Th2/Th3/Th17-related genes in recurrent aphthous ulcers.
Lewkowicz N; Kur B; Kurnatowska A; Tchorzewski H; Lewkowicz P
Arch Immunol Ther Exp (Warsz); 2011 Oct; 59(5):399-406. PubMed ID: 21805152
[TBL] [Abstract][Full Text] [Related]
28. Increased density of lymphocytes bearing gamma/delta T-cell receptors in recurrent aphthous ulceration (RAU).
Natah SS; Häyrinen-Immonen R; Hietanen J; Patinen P; Malmström M; Savilahti E; Konttinen YT
Int J Oral Maxillofac Surg; 2000 Oct; 29(5):375-80. PubMed ID: 11071244
[TBL] [Abstract][Full Text] [Related]
29. Factor XIIIa-positive dendrocytes are increased in number and size in recurrent aphthous ulcers (RAU).
Natah SS; Häyrinen-Immonen R; Hietanen J; Malmström M; Konttinen YT
J Oral Pathol Med; 1997 Oct; 26(9):408-13. PubMed ID: 9385578
[TBL] [Abstract][Full Text] [Related]
30. [Alteration of Th17 cells, immunoglobins and complements levels in peripheral blood of patients with refractory recurrent aphthous ulcer].
Yang LL; Wang WM; Liu YJ; Jiang TW; Wang BL
Shanghai Kou Qiang Yi Xue; 2017 Oct; 26(5):521-525. PubMed ID: 29308514
[TBL] [Abstract][Full Text] [Related]
31. Gamma delta T-cell fraction of peripheral blood is increased in recurrent aphthous ulceration.
Pedersen A; Ryder LP
Clin Immunol Immunopathol; 1994 Jul; 72(1):98-104. PubMed ID: 8020200
[TBL] [Abstract][Full Text] [Related]
32. Deposits of immunoglobulin G and complement C3 in recurrent aphthous ulcerations.
Donatsky O; Dabelsteen E
Scand J Dent Res; 1977 Sep; 85(6):419-25. PubMed ID: 339319
[TBL] [Abstract][Full Text] [Related]
33. Serum IgA, IgG, IgM and salivary IgA in recurrent aphthous ulceration.
Brozović S; Vucićević-Boras V; Buković D
Coll Antropol; 2001 Dec; 25(2):633-7. PubMed ID: 11817364
[TBL] [Abstract][Full Text] [Related]
34. Decreased CD4+/CD8+ ratio in major type of recurrent aphthous ulcers: comparing major to minor types of ulcers.
Bachtiar EW; Cornain S; Siregar B; Raharjo TW
Asian Pac J Allergy Immunol; 1998; 16(2-3):75-9. PubMed ID: 9876944
[TBL] [Abstract][Full Text] [Related]
35. Anticoagulant and Fibrinolytic Disorders in Patients with Behçet's Disease and Recurrent Aphthous Ulcer.
Shang H; Ye JJ; Ji M; Wang FF; Zhu YY; Qi XM
Chin J Physiol; 2011 Aug; 54(4):235-40. PubMed ID: 22129821
[TBL] [Abstract][Full Text] [Related]
36. [Innate immunity participation in the pathogenesis of endometriosis].
Kamer-Bartosińska A; Szyłło K; Tchórzewski H; Lewy J
Ginekol Pol; 2003 Sep; 74(9):959-67. PubMed ID: 14674152
[TBL] [Abstract][Full Text] [Related]
37. Mechanisms of depressed natural killer cell activity in recurrent aphthous ulcers.
Sun A; Chu CT; Wu YC; Yuan JH
Clin Immunol Immunopathol; 1991 Jul; 60(1):83-92. PubMed ID: 1904331
[TBL] [Abstract][Full Text] [Related]
38. Evidence for control of tumour necrosis factor-alpha (TNF-alpha) activity by TNF receptors in patients with proliferative diabetic retinopathy.
Limb GA; Soomro H; Janikoun S; Hollifield RD; Shilling J
Clin Exp Immunol; 1999 Mar; 115(3):409-14. PubMed ID: 10193411
[TBL] [Abstract][Full Text] [Related]
39. [Effects of dihydromyricetin on tumor necrosis factor and NF-kappaB p65 of RAU rats].
Yang XM; Wang XH; Chen LF; Wang XQ
Zhongguo Zhong Yao Za Zhi; 2012 Sep; 37(17):2612-7. PubMed ID: 23236762
[TBL] [Abstract][Full Text] [Related]
40. Serum interleukin-8 level is a more sensitive marker than serum interleukin-6 level in monitoring the disease activity of recurrent aphthous ulcerations.
Sun A; Chang YF; Chia JS; Chiang CP
J Oral Pathol Med; 2004 Mar; 33(3):133-9. PubMed ID: 15128054
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]